1 Min Read
March 9 (Reuters) - Intec Pharma Ltd:
* INTEC PHARMA REPORTS FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS AND BUSINESS UPDATE
* Q4 LOSS PER SHARE $0.39 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.